122 related articles for article (PubMed ID: 28458156)
21. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.
Yao X; Xia F; Tang W; Xiao C; Yang M; Zhou B
J Ethnopharmacol; 2018 Feb; 212():208-215. PubMed ID: 29031784
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats.
He Q; Li JK; Li F; Li RG; Zhan GQ; Li G; Du WX; Tan HB
World J Gastroenterol; 2015 Feb; 21(7):2058-66. PubMed ID: 25717238
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of CCL19 benefits non‑alcoholic fatty liver disease by inhibiting TLR4/NF‑κB‑p65 signaling.
Zhao J; Wang Y; Wu X; Tong P; Yue Y; Gao S; Huang D; Huang J
Mol Med Rep; 2018 Nov; 18(5):4635-4642. PubMed ID: 30221732
[TBL] [Abstract][Full Text] [Related]
24. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
Jiang Y; Chen L; Wang H; Narisi B; Chen B
J Ethnopharmacol; 2015 Dec; 176():499-507. PubMed ID: 26571089
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D nanoemulsion enhances hepatoprotective effect of conventional vitamin D in rats fed with a high-fat diet.
El-Sherbiny M; Eldosoky M; El-Shafey M; Othman G; Elkattawy HA; Bedir T; Elsherbiny NM
Chem Biol Interact; 2018 May; 288():65-75. PubMed ID: 29653100
[TBL] [Abstract][Full Text] [Related]
26. CGplus, a standardized herbal composition ameliorates non-alcoholic steatohepatitis in a tunicamycin-induced mouse model.
Lee MM; Kim HG; Lee SB; Lee JS; Kim WY; Choi SH; Lee SK; Byun CK; Hyun PM; Son CG
Phytomedicine; 2018 Mar; 41():24-32. PubMed ID: 29519316
[TBL] [Abstract][Full Text] [Related]
27. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
Kathirvel E; Morgan K; French SW; Morgan TR
Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233
[TBL] [Abstract][Full Text] [Related]
28. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.
Jiang W; Guo MH; Hai X
World J Gastroenterol; 2016 Dec; 22(46):10180-10188. PubMed ID: 28028366
[TBL] [Abstract][Full Text] [Related]
29. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats.
Wang Y; Li JY; Han M; Wang WL; Li YZ
Lipids Health Dis; 2015 Aug; 14():85. PubMed ID: 26242978
[TBL] [Abstract][Full Text] [Related]
30. [Emodin worsens methionine-choline-deficient diet-induced non-alcoholic fatty liver disease in mice].
Liu Q; Yu F; Yu N; Shi M; Wang F
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):620-4. PubMed ID: 25940288
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease.
Yamada H; Ohashi K; Suzuki K; Munetsuna E; Ando Y; Yamazaki M; Ishikawa H; Ichino N; Teradaira R; Hashimoto S
Clin Chim Acta; 2015 Jun; 446():267-71. PubMed ID: 25958847
[TBL] [Abstract][Full Text] [Related]
32. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
[TBL] [Abstract][Full Text] [Related]
33. Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds.
Ragab SM; Abd Elghaffar SKh; El-Metwally TH; Badr G; Mahmoud MH; Omar HM
Lipids Health Dis; 2015 Jul; 14():83. PubMed ID: 26228038
[TBL] [Abstract][Full Text] [Related]
34. Protective effects of Kangxian ruangan capsule against nonalcoholic fatty liver disease fibrosis in rats induced by MCD diet.
Liu L; Zhou Y; Dai D; Xia H; Zhao K; Zhang J
Biomed Pharmacother; 2018 Dec; 108():424-434. PubMed ID: 30236852
[TBL] [Abstract][Full Text] [Related]
35. Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats.
Cui WX; Yang J; Chen XQ; Mao Q; Wei XL; Wen XD; Wang Q
Am J Chin Med; 2013; 41(3):487-502. PubMed ID: 23711137
[TBL] [Abstract][Full Text] [Related]
36. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.
Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996
[TBL] [Abstract][Full Text] [Related]
37. Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats.
Saleh DO; Ahmed RF; Amin MM
Appl Physiol Nutr Metab; 2017 Mar; 42(3):243-249. PubMed ID: 28177750
[TBL] [Abstract][Full Text] [Related]
38. Total sesquiterpene glycosides from Loquat (Eriobotrya japonica) leaf alleviate high-fat diet induced non-alcoholic fatty liver disease through cytochrome P450 2E1 inhibition.
Jian T; Ao X; Wu Y; Lv H; Ma L; Zhao L; Tong B; Ren B; Chen J; Li W
Biomed Pharmacother; 2017 Jul; 91():229-237. PubMed ID: 28458161
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
Qin R; Zhang J; Li C; Zhang X; Xiong A; Huang F; Yin Z; Li K; Qin W; Chen M; Zhang S; Liang L; Zhang H; Nie H; Ye W
Arch Pharm Res; 2012 Jul; 35(7):1241-50. PubMed ID: 22864747
[TBL] [Abstract][Full Text] [Related]
40. Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Sato K; Gosho M; Yamamoto T; Kobayashi Y; Ishii N; Ohashi T; Nakade Y; Ito K; Fukuzawa Y; Yoneda M
Nutrition; 2015; 31(7-8):923-30. PubMed ID: 26059365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
